Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -61738.00% is 619% below its 5-year average of -8592.51%, near the low end of its 5-year range (-78692.86%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-61738.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-6958.71%
OPERATING MARGIN AVG 5Y
-8592.51%
OPERATING MARGIN AVG 10Y
-2747.28%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-787.20%
CURRENT VS 5Y AVG
-618.51%
CURRENT VS 10Y AVG
-2147.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
INmune Bio, Inc.
Market Cap
$49.45M
Operating Margin
-61738.00%
TTM Avg
0.00%
3Y Avg
-6958.71%
5Y Avg
-8592.51%
Market Cap
$49.55M
Operating Margin
-37.50%
TTM Avg
-9.07%
3Y Avg
3.39%
5Y Avg
-9.53%
Market Cap
$49.61M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$49.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$49.21M
Operating Margin
-42.56%
TTM Avg
-45.64%
3Y Avg
-65.22%
5Y Avg
-83.27%
Market Cap
$49.79M
Operating Margin
-230.92%
TTM Avg
-150.83%
3Y Avg
-322.13%
5Y Avg
-477.29%
Market Cap
$50.01M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$50.51M
Operating Margin
N/A
TTM Avg
-19.41%
3Y Avg
-9.70%
5Y Avg
-6.47%
Market Cap
$50.59M
Operating Margin
-11541.50%
TTM Avg
-10608.91%
3Y Avg
-9412.76%
5Y Avg
-9062.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $49.45M | -61738.00% | 0.00% | -6958.71% | -8592.51% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | -37.50% | -9.07% | 3.39% | -9.53% |
| Apollomics, Inc. (APLM)vs › | $49.61M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| Microbot Medical Inc. (MBOT)vs › | $49.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -42.56% | -45.64% | -65.22% | -83.27% |
| Celularity Inc. (CELU)vs › | $49.79M | -230.92% | -150.83% | -322.13% | -477.29% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.51M | N/A | -19.41% | -9.70% | -6.47% |
| Clene Inc. (CLNN)vs › | $50.59M | -11541.50% | -10608.91% | -9412.76% | -9062.71% |
| Envoy Medical, Inc. (COCH)vs › | $50.61M | -9240.66% | -8899.44% | -6820.53% | -4916.43% |
Gross Margin
100.0%
Operating Margin
-61738.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -19810.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -78692.86% |
| 2023-12-31 | -29925.00% |
| 2023-09-30 | -19832.56% |
| 2023-06-30 | -13936.96% |
| 2023-03-31 | -16902.63% |
| 2022-12-31 | -5816.49% |
| 2022-09-30 | -7594.90% |
| 2022-06-30 | -39925.00% |
| 2022-03-31 | -3974.23% |
| 2021-12-31 | -5539.88% |
| 2021-09-30 | -64435.71% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -113700.00% |
| 2020-12-31 | -29172.73% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
